Jielin Liu
9 Beijing Road
Guiyang, 550004, China
Guiyang, 550004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Derived from fangchinoline, LYY-35 exhibits an inhibiting effect on human NSCLC cancer A549 cells.
Journal: Journal of Cancer
Published: March 24, 2024
Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 20, 2023
Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis.
Journal: Cancer cell international
Published: April 20, 2023
Correction to: Bio-electrospraying is a safe technology for delivering human adipose-derived stem cells.
Journal: Biotechnology letters
Published: February 19, 2021
Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
Journal: BMC cancer
Published: December 10, 2018
Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase.
Journal: BMC cancer
Published: July 03, 2018
Preparation, characterization and application of monoclonal antibody against RecQ helicase
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: April 21, 2018
Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib.
Journal: OncoTargets and therapy
Published: January 15, 2015
Bio-electrospraying is a safe technology for delivering human adipose-derived stem cells.
Journal: Biotechnology letters
Published: June 29, 2014
Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.
Journal: Oncology letters
Published: April 25, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026